| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |